What is the expected impact of the Nasdaq listing under the new ticker HIND on liquidity and trading volume?

Liquidity & Volume Outlook – The Nasdaq approval effectively creates a single, larger public float that combines Vyome’s and ReShape’s outstanding shares. The merger will bring the combined company’s market‑cap into the mid‑low‑hundreds‑of‑millions range, which is comfortably above the typical “micro‑cap” thresholds that constrain depth on the Nasdaq. As a result, market makers are likely to assign a larger quote size and tighter spreads, immediately improving order‑book depth. The new ticker HIND will also draw attention from Nasdaq‑focused institutional investors and quantitative funds that screen for newly‑listed symbols, so we can expect an initial surge in daily volume—historically, similar reverse‑merger listings see a 30‑50 % jump in the first week relative to the pre‑merger averages of the two legacy securities.

Trading Implications – The short‑term price action will probably be volatile as investors digest the combined pipeline, re‑price the equity and adjust positions in response to the expanded float. Traders should look for a strong opening range breakout on Aug 15 and then monitor the first 30‑60 minutes for volume‑driven price spikes; a pull‑back to the opening‑range low can offer a relatively low‑risk entry with a stop just below that level. On the technical side, the merged stock will inherit a fresh 20‑day moving‑average that will sit near the initial post‑listing price, providing a clear short‑term trend filter. Over the medium term, sustained elevated volume (well above the 1‑million‑share daily threshold) will signal that liquidity is stabilizing, allowing larger positions without excessive market impact. Conversely, if volume tapers quickly, it could indicate limited investor interest and higher execution risk—something to watch before scaling in.